SiNtx Technologies Inc (SINT)

[Millstone]

Not seeing Amedica with the same pessimistic eye. In fact, I think they are on the cusp of a turnaround.

Valuation is extremely low on a P/S basis and a market cap basis. They have done a great job eliminating the toxic convertibles while also paying down debt.

Plenty of upside from focused attention on their current products, which they claim to be doing. Future upside from a great pipeline of truly superior advancements in materials science for implants.

Not to mention the China deal with mandatory minimums.

They are heading in the right direction.

The CEO is relatively new to AMDA. He inherited some issues to be sure, but he is moving the company in the right direction.

If the composite interbody device is approved by the FDA, that is huge for AMDA. Imagine not having to use cadaver or autologous bone in a spinal surgery with its attendant infection, setting, and adherence risks.

Amedica is going to get bought out before they are allowed to take market share from the big boys. And those with an average of $1 per share cost will reap great rewards.